Molina Healthcare, Inc. (NYSE:MOH) Receives $407.45 Consensus PT from Brokerages

Shares of Molina Healthcare, Inc. (NYSE:MOHGet Free Report) have earned a consensus rating of “Moderate Buy” from the twelve research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $405.18.

A number of research analysts recently issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. JPMorgan Chase & Co. dropped their price target on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research note on Wednesday. Wells Fargo & Company dropped their price target on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating on the stock in a research note on Monday, April 29th. Robert W. Baird initiated coverage on Molina Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $405.00 price target on the stock. Finally, Barclays lowered their target price on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 25th.

Read Our Latest Stock Analysis on MOH

Insider Activity

In other news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the sale, the director now directly owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Ronna Romney sold 250 shares of Molina Healthcare stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the transaction, the director now directly owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO James Woys sold 10,000 shares of the business’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total value of $3,451,500.00. Following the completion of the transaction, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at $18,504,526.95. The disclosure for this sale can be found here. Insiders own 1.11% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in MOH. McIlrath & Eck LLC purchased a new stake in shares of Molina Healthcare in the fourth quarter valued at $34,000. VisionPoint Advisory Group LLC grew its position in Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock valued at $36,000 after acquiring an additional 57 shares during the period. Raleigh Capital Management Inc. grew its position in Molina Healthcare by 40.4% during the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock valued at $41,000 after acquiring an additional 36 shares during the period. Principal Securities Inc. purchased a new stake in Molina Healthcare during the fourth quarter valued at about $42,000. Finally, Householder Group Estate & Retirement Specialist LLC grew its position in Molina Healthcare by 3,933.3% during the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock valued at $43,000 after acquiring an additional 118 shares during the period. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $286.78 on Thursday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49. Molina Healthcare has a fifty-two week low of $284.34 and a fifty-two week high of $423.92. The firm has a market capitalization of $16.81 billion, a PE ratio of 15.56, a price-to-earnings-growth ratio of 0.90 and a beta of 0.58. The stock’s 50-day simple moving average is $318.71 and its 200-day simple moving average is $359.05.

Molina Healthcare (NYSE:MOHGet Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping the consensus estimate of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. During the same quarter last year, the company earned $5.81 EPS. The business’s quarterly revenue was up 21.9% on a year-over-year basis. As a group, equities research analysts forecast that Molina Healthcare will post 23.56 EPS for the current fiscal year.

Molina Healthcare Company Profile

(Get Free Report

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.